News from anthera pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Nov 23, 2014, 21:30 ET

Anthera Pharmaceuticals to Present at Annual Piper Jaffray Healthcare Conference

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), announced today that Paul F. Truex, President and Chief Executive Officer, will present a corporate...

Nov 20, 2014, 11:00 ET

Anthera and Patheon Sign Manufacturing Agreement for Liprotamase Phase III Registration Trial

 Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH) announced today it has signed a manufacturing and supply agreement with the Patheon®...

Nov 14, 2014, 16:05 ET

Anthera Pharmaceuticals Reports 2014 Third Quarter Financial Results and Operational Update

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and operational update for the third quarter ended September 30,...

Oct 01, 2014, 16:00 ET

Anthera Pharmaceuticals Announces Update on Strategic Partnership Discussions for Blisibimod

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH) today confirmed it is engaged in potential partnership negotiations for blisibimod for both lupus...

Jul 28, 2014, 17:40 ET

Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and operational update for the second quarter ended June 30, 2014....

Jul 14, 2014, 16:42 ET

Anthera Pharmaceuticals Announces Acquisition of Sollpura® (liprotamase) for Exocrine Pancreatic Insufficiency From Eli Lilly and Company

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH) today announced that it has acquired Sollpura (liprotamase), a novel investigational Pancreatic Enzyme...

Jun 23, 2014, 17:00 ET

Anthera Pharmaceuticals Appoints Brian R. Mueller to Board of Directors

 Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH), a biopharmaceutical company focused on developing and commercializing products to treat...

Jun 13, 2014, 15:30 ET

Anthera Pharmaceuticals Appoints Dr. Philip Sager to Board of Directors

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune...

May 13, 2014, 08:30 ET

Anthera Pharmaceuticals Reports 2014 First Quarter Financial Results and Operational Update

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and operational update for the first quarter ended March 31, 2014....

Mar 31, 2014, 16:30 ET

Anthera Pharmaceuticals Announces Personnel Changes

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune...

Mar 12, 2014, 18:01 ET

Anthera Pharmaceuticals Reports 2013 Fourth Quarter And Fiscal Year Financial Results and Operational Update

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and operational update for the fourth quarter and year ended...

Jan 30, 2014, 16:42 ET

Anthera Pharmaceuticals to Present at Leerink Swann, Cowen & Co., and BIO CEO Healthcare Conferences

 Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH), a biopharmaceutical company focused on developing and commercializing products to treat...

Nov 27, 2013, 17:00 ET

Anthera Pharmaceuticals to Present at Annual Piper Jaffray Healthcare Conference

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune...

Oct 29, 2013, 16:30 ET

Anthera Pharmaceuticals Reports 2013 Third Quarter Financial Results, Clinical and Regulatory Update

 Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results, clinical and regulatory update for the quarter ended...

Sep 25, 2013, 08:30 ET

Anthera Pharmaceuticals Announces Emerging Data from Phase 2 Open-Label Extension Study to be Presented at the ACR/ARHP 2013 Annual Scientific Meeting

Anthera Pharmaceuticals (NASDAQ: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune...

Jul 30, 2013, 17:14 ET

Anthera Pharmaceuticals Reports 2013 Second Quarter Financial Results

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and business highlights for the quarter ended June 30, 2013....

Jul 12, 2013, 17:00 ET

Anthera Pharmaceuticals Announces 1-for-8 Reverse Split of Stock

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) announced today that it has filed a Certificate of Amendment to its Amended and Restated Certificate...

Jun 24, 2013, 08:30 ET

Anthera Announces Initiation of BRIGHT-SC Phase 2 Clinical Study in IgA Nephropathy with Blisibimod

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with autoimmune...

Jun 21, 2013, 16:45 ET

Anthera Pharmaceuticals Announces Receipt of Nasdaq Notice

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) (the "Company"), a biopharmaceutical company focused on developing and commercializing products...

Jun 12, 2013, 16:30 ET

Anthera Pharmaceuticals Announces Personnel Changes

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) today announced the appointment of May Liu as its Senior Vice President, Finance and...